Please login to the form below

Not currently logged in
Email:
Password:

commercialisation

This page shows the latest commercialisation news and features for those working in and with pharma, biotech and healthcare.

Boehringer’s Corsico to be new GSK drug dev leader

Boehringer’s Corsico to be new GSK drug dev leader

The UK-headquartered firm has underperformed on R&D and commercialisation in recent years, and CEO Emma Walmsley is determined to create a more focused and productive pharma division.

Latest news

More from news
Approximately 0 fully matching, plus 519 partially matching documents found.

Latest Intelligence

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    I think this is the first time ever where a biotech has its first four programmes all heading towards filing and commercialisation in such a short period of time – that’s

  • Reaching the new influencers Reaching the new influencers

    early in drug development and throughout commercialisation, gathering insights to identify clinically meaningful differentiators by engaging with the external community years ahead of launch.

  • Brexit Means Brexit Brexit Means Brexit

    CPPs, which establish the status of a pharmaceutical in the exporting country, are required by importing countries to ensure the product being registered or renewed aligns with the scope of commercialisation

  • Deal Watch January 2018

    Up to $75m per product in sales milestones. On option exercise Denali and Takeda will share 50:50 development/commercialisation costs and share profits.

  • Simplifying HCP access to digital information Simplifying HCP access to digital information

    On the other hand, Align Biopharma is tackling long-standing challenges in the commercialisation of drugs and treatments, and how HCPs engage with life science companies.

More from intelligence
Approximately 1 fully matching, plus 105 partially matching documents found.

Latest appointments

  • BMS appoints CCO, Stephen Davies joins Eisai and more BMS appoints CCO, Stephen Davies joins Eisai and more

    His new role builds on his career history surrounding drug development through to commercialisation in both pharma and biotech industries.

  • Weekly industry appointments Weekly industry appointments

    Commenting on the new appointment, Keith Thompson, chief executive of CGT Catapult, said: “With over 20 years’experience in R&D, Jonathan has both commercialisation and drug development expertise. ... be a global leader in the development and

  • Gamida Cell strengthens leadership team Gamida Cell strengthens leadership team

    Their combined experience in corporate strategy, business development and commercialisation will be invaluable to the company’s continued growth as we advance our clinical programmes in blood cancers and rare genetic

  • Abeona Therapeutics names CEO Abeona Therapeutics names CEO

    Steven Rouhandeh, executive chairman of Abeona, said: “As CEO, Carsten Thiel brings a unique combination of extensive experience in research and global rare disease commercialisation to Abeona.

  • Zelluna Immunotherapy appoints chief technology officer Zelluna Immunotherapy appoints chief technology officer

    He will play a big part in the execution of Zelluna’s manufacturing strategy for clinical trials and commercialisation.”.

More from appointments
Approximately 0 fully matching, plus 119 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 32 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics